ангиотензин 1 型受体的激活促进神经元和质细胞的α-synuclein 聚合和传播
Lucia Lage1, Ana I Rodriguez-Perez1,2, Begoña Villar-Cheda1,2
1Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
NPJ Parkinson's disease
|February 17, 2024
概括
大脑氨酸- ангиотензин系统 (RAS) 的过度激活促进了α-synuclein的聚合和扩散,恶化了帕金森病的进展. 阻断血管激素II型1受体 (AT1) 可能提供治疗效益.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 大脑的氨酸- ангиотензин系统 (RAS) 参与了多巴胺变性退化.
- 血管激素II (AngII) 1型受体 (AT1) 基因的高表达标志着帕金森病 (PD) 中脆弱的神经元.
研究的目的:
- 调查AngII/AT1过度激活是否影响α-synuclein聚合和传播.
- 探索大脑RAS失调在PD病变发生过程中的作用.
主要方法:
- 在多巴胺能神经元和微质细胞的体外研究.
- 使用MPTP诱导的帕金森症小鼠模型的体内研究.
- 治疗AT1阻断剂 (telmisartan) 和AT1敲击小鼠.
- 跨共同培养系统来评估细胞对细胞的传播.
主要成果:
- AngII/AT1激活通过NADPH氧化酶和信号传递增加了α-synuclein聚合.
- 在小鼠中,AngII/AT1激活加剧了MPTP诱导的α-synuclein变化.
- AngII增强了α-synuclein的微质细胞吸收和质细胞转移,但没有神经元释放.
- AT1阻断显著降低了α-synuclein的聚合和表达.
结论:
- 大脑RAS失调是帕金森病进展的关键机制.
- AT1受体抑制和RAS调制是PD的潜在治疗策略.
相关概念视频
Enzyme-linked Receptors
78.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.4K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Adrenergic Neurons: Neurotransmission
3.8K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.8K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


